To identify whether linc00976 was abnormally expressed in CCA and determine its effect on prognosis, ISH and RT-qPCR were used to verify linc00976 expression levels in bile duct adjacent/tumor tissues and normal/cancer cell lines, and overall survival analysis was used to evaluate prognosis risk. This evidence concerns the gene CCDC26 and cholangiocarcinoma.